| 영문 | gigantism | 한글 | 거인증 |
|---|---|---|---|
| 설명 | 뇌하수체의 성장호르몬을 분비하는 세포에서 종양이 생겼을 경우에 과도한 성장 호르몬의 생성으로 발생되는 병이다. 뼈에서 길이의 성장을 담당하는, 연골로 구성되어 있는 부위인 뼈끝이 연골에서 뼈가 생성 되어서 뼈의 길이의 성장이 일어난다. 성장이 다 된 뼈에서는 이 연골판이 없어지게 되어 양쪽의 뼈가 융합이 되고 이것이 있던 부위에 하나의 선만이 남게 된다. 뼈끝 융합이 일어나기 전에 종양이 생겼을 때는 거인증(giantism)이 일어나지만 뼈끝융합이 일어난 후에 생겼을 때는 말단비대증(acromegaly)이라는 병이 일어난다. 거인증은 소아기에는 매우 드물며, 대부분이 과도한 성장이 있는 사춘기에 일어난다. 과도한 성장호르몬의 분비에 의해서 뼈, 연골, 섬유조직 등의 과도한 성장이 있게 된다. 일반적으로 자각 증상은 없는 경우가 보통이며 있는 경우도 있지만 아주 경미하다. 머리뼈나 아래턱뼈가 아주 두터워지고 모든 뼈의 굵기나 크기가 증가된다. 뼈의 기능은 모두 정상이나 근육의 힘이 약해 있는 것이 대부분이다. 검사상으로 혈액중에 성장 호르몬치가 높으며, 치료는 외과적으로 뇌하수체에 생긴 종양을 절제하는 방법과 방사선을 쬐어서 그 종양을 없애는 방법이 있다. |
||
| DGS | decompression sickness; developmental Gerstmann syndrome; diabetic glomerulosclerosis; Di George seq... |
|---|---|
| DGSX | X-linked dysplasia gigantism syndrome |
| EMG | electromyogram, electromyography; eye movement gauge; exomphalosmacroglossia-gigantism [syndrome] |
| FHR | Foetal heart rate |
|---|---|
| IUGR | Intrauterine foetal growth retardation |
| foetal gigantism | Excessive foetal or newborn size, e.g., cerebral gigantism and infants of diabetic mothers. (05 Mar 2000) |
|---|
| acromegalic gigantism | A form of pituitary gigantism in which the signs of acromegaly accompany abnormal height. (05 Mar 2000) |
|---|---|
| gigantism | A condition where there is over-production of growth hormone by the pituitary gland in a child before the bone growth plates close, resulting in excessive long bone growth. (27 Sep 1997) |
| cerebral gigantism | A syndrome characterised by increased birth weight and length (above 90th percentile), accelerated growth rate for the first 4 or 5 years without elevation of serum growth hormone levels, and then reversion to normal growth rate; characteristic facies include prognathism, hypertelorism, antimongoloid slant, and dolichocephalic skull; moderate mental retardation and impaired coordination are also associated. See: Sotos' syndrome. (05 Mar 2000) |
| pituitary gigantism | Excessive growth due to overactivity of the pituitary gland (specifically of the anterior pituitary). (12 Dec 1998) |
| primordial gigantism | Unusually large size from birth due to familial or genetic factors or intrauterine environment (e.g., maternal prediabetic state) and not to hyperpituitarism. (05 Mar 2000) |
| eunuchoid gigantism | Gigantism with deficient development of sexual organs; may be of pituitary or gonadal origin; gigantism accompanied by body proportions typical of hypogonadism during adolescence. (05 Mar 2000) |
| focal gigantism | <radiology> Neurofibromatosis, AVM, Klippel-Trenaunay-Weber syndrome, Beckwith-Wiedemann syndrome, Parks-Davis syndrome, haemangioma, JRA (12 Dec 1998) |
| baby, foetal alcohol syndrome | <syndrome> Alcohol is capable of causing birth defects. FAS (foetal alcohol syndrome) always involves brain damage. And impaired growth. FAS also always involves head and face abnormalities. No amount of alcohol has been proven safe during pregnancy. Women who are or may become pregnant are advised to avoid alcohol. (12 Dec 1998) |
| baseline foetal heart rate | <paediatrics> The average heart rate for a particular foetus during the diastolic phase of uterine contractions. (05 Mar 2000) |
| baseline variability of foetal heart rate | The beat-to-beat changes in foetal heart rate as recorded on a graph. (05 Mar 2000) |
| rate, foetal mortality | The ratio of foetal deaths divided by the sum of the births (the live births + the foetal deaths) in that year. In the united states, the foetal mortality rate plummeted from 19.2 per 1,000 births in 1950 to 9.2 per 1,000 births in 1980. (12 Dec 1998) |
| marked foetal bradycardia | A foetal heart rate less than 100 beats per minute. (05 Mar 2000) |
| version, foetal | The manual conversion of or changing of the polarity of the foetus with reference to the mother. (12 Dec 1998) |
| maternal-foetal exchange | Exchange of substances between the maternal blood and the foetal blood through the placental barrier. It excludes microbial or viral transmission. (12 Dec 1998) |
| persistent foetal circulation syndrome | <syndrome> A syndrome of persistent pulmonary hypertension in the newborn infant, without demonstrable cardiac disease. It is characterised by cyanosis and acidosis, severe pulmonary vasoconstriction, hypertrophy of pulmonary arterial muscle, and elevated pulmonary vascular resistance, with resultant right-to-left shunting of blood through a patent ductus arteriosus and at times a patent foramen ovale. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|